321 related articles for article (PubMed ID: 9927335)
1. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice.
Takeda S; Yoshizawa T; Nagai Y; Yamato H; Fukumoto S; Sekine K; Kato S; Matsumoto T; Fujita T
Endocrinology; 1999 Feb; 140(2):1005-8. PubMed ID: 9927335
[TBL] [Abstract][Full Text] [Related]
2. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro.
Li X; Okada Y; Pilbeam CC; Lorenzo JA; Kennedy CR; Breyer RM; Raisz LG
Endocrinology; 2000 Jun; 141(6):2054-61. PubMed ID: 10830290
[TBL] [Abstract][Full Text] [Related]
3. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice.
Starczak Y; Reinke DC; Barratt KR; Russell PK; Clarke MV; Davey RA; Atkins GJ; Anderson PH
J Steroid Biochem Mol Biol; 2021 Jun; 210():105857. PubMed ID: 33647520
[TBL] [Abstract][Full Text] [Related]
5. VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption.
Nakamichi Y; Udagawa N; Horibe K; Mizoguchi T; Yamamoto Y; Nakamura T; Hosoya A; Kato S; Suda T; Takahashi N
J Bone Miner Res; 2017 Jun; 32(6):1297-1308. PubMed ID: 28177161
[TBL] [Abstract][Full Text] [Related]
6. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts.
Bi Y; Nielsen KL; Kilts TM; Yoon A; A Karsdal M; Wimer HF; Greenfield EM; Heegaard AM; Young MF
Bone; 2006 Jun; 38(6):778-86. PubMed ID: 16364709
[TBL] [Abstract][Full Text] [Related]
7. The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo.
Mori T; Horibe K; Koide M; Uehara S; Yamamoto Y; Kato S; Yasuda H; Takahashi N; Udagawa N; Nakamichi Y
Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32987399
[TBL] [Abstract][Full Text] [Related]
8. Osteoblastic cells are involved in osteoclast formation.
Takahashi N; Akatsu T; Udagawa N; Sasaki T; Yamaguchi A; Moseley JM; Martin TJ; Suda T
Endocrinology; 1988 Nov; 123(5):2600-2. PubMed ID: 2844518
[TBL] [Abstract][Full Text] [Related]
9. VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts.
Willems HM; van den Heuvel EG; Carmeliet G; Schaafsma A; Klein-Nulend J; Bakker AD
Steroids; 2012 Jan; 77(1-2):126-31. PubMed ID: 22093484
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
11. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
Masuyama R; Stockmans I; Torrekens S; Van Looveren R; Maes C; Carmeliet P; Bouillon R; Carmeliet G
J Clin Invest; 2006 Dec; 116(12):3150-9. PubMed ID: 17099775
[TBL] [Abstract][Full Text] [Related]
13. Estrogen blocks parathyroid hormone-stimulated osteoclast-like cell formation in modulating differentiation of mouse marrow stromal cells in vitro.
Liu BY; Wu PW; Hsu YT; Leu JS; Wang JT
J Formos Med Assoc; 2002 Jan; 101(1):24-33. PubMed ID: 11911034
[TBL] [Abstract][Full Text] [Related]
14. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts.
Tachi K; Takami M; Zhao B; Mochizuki A; Yamada A; Miyamoto Y; Inoue T; Baba K; Kamijo R
Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510
[TBL] [Abstract][Full Text] [Related]
16. Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts.
Otsuka E; Notoya M; Hagiwara H
Calcif Tissue Int; 2003 Jul; 73(1):72-7. PubMed ID: 14506957
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time.
Tsurukai T; Takahashi N; Jimi E; Nakamura I; Udagawa N; Nogimori K; Tamura M; Suda T
J Cell Physiol; 1998 Oct; 177(1):26-35. PubMed ID: 9731742
[TBL] [Abstract][Full Text] [Related]
18. The vitamin D receptor in osteoblastic cells but not secreted parathyroid hormone is crucial for soft tissue calcification induced by the proresorptive activity of 1,25(OH)
Nakamichi Y; Liu Z; Mori T; He Z; Yasuda H; Takahashi N; Udagawa N
J Steroid Biochem Mol Biol; 2023 Sep; 232():106351. PubMed ID: 37352941
[TBL] [Abstract][Full Text] [Related]
19. Lack of bone resorption in osteosclerotic (oc/oc) mice is due to a defect in osteoclast progenitors rather than the local microenvironment provided by osteoblastic cells.
Udagawa N; Sasaki T; Akatsu T; Takahashi N; Tanaka S; Tamura T; Tanaka H; Suda T
Biochem Biophys Res Commun; 1992 Apr; 184(1):67-72. PubMed ID: 1567458
[TBL] [Abstract][Full Text] [Related]
20. Chinese hamster ovary cells expressing alpha4beta1 integrin stimulate osteoclast formation in vitro.
Akatsu T; Ono K; Murakami T; Katayama Y; Nishikawa M; Wada S; Yamamoto M; Kugai N; Matsuura N; Takada Y; Nagata N
J Bone Miner Res; 1998 Aug; 13(8):1251-9. PubMed ID: 9718193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
